Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection
about
Recent developments in drug discovery for leishmaniasis and human African trypanosomiasisCombination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasisA screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?The Use of Gene Ontology Term and KEGG Pathway Enrichment for Analysis of Drug Half-LifeImipramine alters the sterol profile in Leishmania amazonensis and increases its sensitivity to miconazole.Vaccination against a virus-encoded cytokine significantly restricts viral challengeTreatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?Drug delivery: lessons to be learnt from Leishmania studies.Investigational drugs for visceral leishmaniasis.Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art.Simple colorimetric trypanothione reductase-based assay for high-throughput screening of drugs against Leishmania intracellular amastigotes.Miltefosine Resistant Field Isolate From Indian Kala-Azar Patient Shows Similar Phenotype in Experimental Infection.Cholesterol-lowering drug, in combination with chromium chloride, induces early apoptotic signals in intracellular L. donovani amastigotes, leading to death.In vitro screening of known drugs identified by scaffold hopping techniques shows promising leishmanicidal activity for suramin and netilmicin.
P2860
Q27011766-2DA0C098-719B-48C7-8444-9B675397D9AAQ27341915-6D0908BC-1065-46E6-979F-00FD46EBA8EAQ28541690-FD576FFF-DDF0-41F8-A710-1EA8622A3921Q28552953-CB027C2D-CB1C-4DFF-9529-2BD928D1702DQ35977108-F5B2C5AF-6C8D-40F7-91A3-AD41BF71755DQ37252720-4359E95C-D6E7-410B-9773-BBF8FF88B824Q38209866-02EBA129-237B-4A52-89AF-D88FEFDDDC87Q38254087-50AC3AAE-44F3-453F-B3E7-D815D81F6522Q38269581-6C6E8FB8-6B86-4CFD-893C-33E32CE58AFDQ38939544-092FAF8D-9891-435F-90B8-8CD9B9C3B0ADQ39067203-061A39F5-FBE0-426D-867D-F005FEAFDE87Q40067217-17732726-3A7D-4832-8A4B-276114973F37Q49866040-4B07920C-E291-4119-91C0-D0BCF4601BB8Q55240622-B6C8492C-074E-43F4-9579-C8577782F39E
P2860
Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Imipramine is an orally active ...... ates in experimental infection
@ast
Imipramine is an orally active ...... ates in experimental infection
@en
Imipramine is an orally active ...... ates in experimental infection
@nl
type
label
Imipramine is an orally active ...... ates in experimental infection
@ast
Imipramine is an orally active ...... ates in experimental infection
@en
Imipramine is an orally active ...... ates in experimental infection
@nl
prefLabel
Imipramine is an orally active ...... ates in experimental infection
@ast
Imipramine is an orally active ...... ates in experimental infection
@en
Imipramine is an orally active ...... ates in experimental infection
@nl
P2093
P2860
P3181
P1476
Imipramine is an orally active ...... ates in experimental infection
@en
P2093
Anjan Kumar Das
Jean Claude Dujardin
Kshudiram Naskar
Rupkatha Mukhopadhyay
Sandip Mukherjee
Syamal Roy
P2860
P3181
P356
10.1371/JOURNAL.PNTD.0001987
P407
P577
2012-01-01T00:00:00Z